#83, The G|O Briefing, January 27, 2022
Sanctions on Putin could cripple International Geneva - A new European push to move forward on a IP waiver for Covid-19 vaccines - The ECOSOC decoded!
TRIPS WAIVER
With a WTO deadlocked over the TRIPS waiver issue, France and the EU make a renewed effort to break the stalemate
France and the EU are actively engaged in a push to break the impasse over the stalled WTO TRIPS waiver negotiations. They hope the upcoming EU-Africa Summit, scheduled to take place in Brussels on February 17 and 18, will bring new momentum to the discussions. Diplomatic sources tell The Geneva
#79 The G|O Briefing, December 9, 2021
VACCINES AND POLITICS: A SOUR MIX | GREENING FINANCE WILL REQUIRE GLOBALLY ACCEPTED ACCOUNTING STANDARDS. ARE THERE TOO MANY?
Hoping for a wow at WHA
One would have hoped that the COVID-19 pandemic would have been met by a coordinated, collective, and global response. Instead, the exact opposite happened.
#64 The G|O Briefing, July 29, 2021
Could 'systemic racism' be hurting the human rights cause? Plus, climate change: the IPCC hard at work–and a pandemic is not enough to keep WTO open..
#62 The G|O Briefing, July 22, 2021
China and the UN: ‘ undue influence?’ asks a new report. Plus, might IP rights on Covid-19 finally be temporarily waived? Don't bet on it.
#56 The G|O Briefing, May 12, 2021
A major victory for civil society - Independent panel says Covid pandemic was preventable - The Bergamo files: Ranieri Guerra presents its defence
#55 The G|O Briefing, May 5, 2021
The Biden administration supports the WTO waiver proposal. International Geneva under the shock of the announcement.
In a U-turn, the Biden administration backs waiving patents on COVID-19 patents
The Biden administration backs waiving WTO intellectual property protections for COVID-19 Vaccines. The surprise move by the White House lauded by advocacy groups is expected to break a six months stalemate in the talks on the initiative led by India and South Africa.
"That's a shock. This
TRIPS Waiver proposal in Geneva mobilizes lobbyists in capitals around the world
Feeling the heat, Big Pharma has been using its financial clout to push back and engage in a frantic lobbying effort to influence governments not to join the project, documents from the US Senate and other organizations show.